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Abstract Semiconductor nanomaterials tagged with
biomarkers may be used for an early fluorescence-based
detection of breast cancer. ZnO nanoparticles are water-
soluble, non-toxic, photo-chemically stable with highly
fluorescence applicability and are regarded for their pos-
sible biocompatibility. As a long-term research planning,
we are aiming to use QDs conjugated with serum-
biomarker for the diagnosis of breast cancer. The present
work is a part in the said direction and reports preliminary
observations on the synthesis and conjugation of ZnO
nanoparticles with a representative protein marker.
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Introduction
Quantum dots (e.g., CdS, CdSe, CdTe, ZnS, PbS) are one
of the nanoparticles that are used in imaging, detection and
targeting. These are nanometre-size luminescent semicon-
ductor crystals and have unique chemical and physical
properties due to their size and their highly compact
structure (Nie et al. 2007; Ferrari 2005; Langer 1998;
Duncan 2003; Li et al. 2004; Allen 2002). They emit dif-
ferent wavelengths over a broad range of the light spectrum
from visible to infrared, depending on their size and
chemical composition (Moussodia et al. 2008). Eventual
use of nanoparticles to dramatically improve clinical
diagnostic tests for the early detection of cancer and other
(Meulenkamp 1998; Jain 1998). The use of quantum dots
heralds a revolution in biological imaging. The current and
widely used organic fluorophores have two shortcomings
associated with their fluorescence (Srinivas et al. 2002).
Signals from the labelled molecules can be obscured by
cell auto fluorescence, occurring in the visible spectrum
and by photobleaching, which seriously limits observation
time (Neuwalt et al. 2004; Gondal et al. 2009). Colloidal
quantum dots are bright, photostable fluorophores of a few
nanometers in diameter. Because their size approximates
that of individual biomolecule, water-soluble nanoparticles
complex have been used to target and image tumour cells.
Despite their advantages, the best materials for nanoparti-
cles cadmium sulphide, CdS and cadmium selenide, CdSe
can be highly toxic because of quantum confinement region
span the entire optical spectrum. Cd ions are able to bind to
thiol molecules in mitochondria to cause significant cell
death (Gorla et al. 1999). These NPs may also damage
DNA and disrupt cell activity from factors such as surface
coating them where we prepare biocompatible semicon-
ductor NPs like ZnO remarkable photochemical stability
and several properties, including size-dependent broad
emission, very high extinction coefficient, readily size-
tunable narrow emission, high fluorescence quantum yields
and use for disease diagnostics like cancer, neurological
disorders etc. (Haase et al. 1988; He et al. 2008; Singh
et al. 2005; Thareja and Shukia 2007; Wang et al. 2003;
Wong et al. 1998). Proteins conjugation like BSA with
nanoparticles attempts have been made for applications
such as fluorescence labelling, immunoassays including
FRET, disease diagnosis etc. (Mohanta et al. 2008; Xie
et al. 2003; Terpetsching et al. 1994). The presence of
antibodies that interact with BSA might serve as a diag-
nostic tool for detection of high-risk patients Kagn Kerman
Pawan Kumar (&)  Parveen Kumar  A. Deep 
L. M. Bharadwaj
Biomolecular Electronics and Nanotechnology Division,
Central Scientific Instruments Organization (CSIR-CSIO),
Sector 30C, Chandigarh 160030, India
e-mail: pawannano10@live.com
123
Appl Nanosci (2013) 3:141–144
DOI 10.1007/s13204-012-0101-0
(2007). The presence of antibodies reacting with BSA in
sera from HEV-infected patients may play a major patho-
genetic role by the generation of autoantibodies.
Presented work includes an overview of applications of
fluorescence microscopy for the diagnosis of cancer with
special emphasis on ZnO nanoparticles. As an alternative
approach for the synthesis of the nanoparticles, chemical
route has been suggested for the synthesis of ZnO NPs,
which have again been conjugated with BSA. The above
steps may be useful for developing an immunosensing
method based upon the use of NPs.
Experimental details
Materials and general method
All the solvent and reagents were analytical grade, commer-
cially available and used as received. The UV–VIS spectros-
copy (Varian, carry 500) studies were carried out in range
200–3,300 nm. The topological studies were carried out using
field emission scanning electrons microscope-energy disper-
sive X-ray spectroscope (FESEM-EDX Hitachi S4800 SE),
dynamic light scattering (DLS) (Brookhaven, BI-200SM).
The functionalization and sensing was taken using photolu-
minescence spectrophometer (Varian, carry 500).
Synthesis of ZnO nanoparticles
The ZnO nanoparticles were synthesized according to
Ralph-olivier Moussodia method. Zinc acetate (220 mg)
was dissolved in hot ethanol (20 ml) under vigorous stir-
ring. Oleic acid (70 ll) was then added and the mixture
was refluxed. In a separate flask, tetramethylammonium
hydroxide (360 mg) was dissolved in refluxing ethanol
(5 ml). This solution was then rapidly injected in the
solution containing zinc acetate and oleic acid. The whole
contents were refluxed for 2 min, and then diluted with
EtOH (50 ml) followed by cooling to 0 C. A white pre-
cipitate of ZnO nanoparticles appeared. The particles were
centrifuged (15 min at 4,000 rpm) for the removal of
supernatant. The resulting oleate capped ZnO QDs were
washed several times with ethanol. After washing, the ZnO
nanoparticles were suspended in 10 ml of toluene and
stored in dark at 4 C.
Conjugation of bovine serum albumin
Before conjugating ZnO nanoparticles with BSA, 5 ml of
ZnO suspension was mixed with 5 ml of 5.0 mg/ml NHS
(made in 100 ll PBS). After 10 min of reaction, the pH of
the solution was adjusted to 7.4 by borate buffer. The
conjugation of ZnO nanoparticles with BSA was achieved
by incubating the above solution with 1 ml of 1.0 mg/ml
BSA for 90 min at 37 C. The contents were stored at
4 C.
Results and discussion
Surface morphological studies have been carried out for
determining the surface texture of the ZnO nanoparticles.
The results of these studies are explained in the following
section:
FESEM image of ZnO nanoparticles showing Fig. 1
their morphological parameters and EDX pattern suggests
the confirmation for synthesis of ZnO nanoparticles. From
both the synthesis routes, the ZnO nanoparticles of \5 nm
could be synthesized. However, the agglomeration of these
nanoparticles was observed in the case where the procedure
2 was adopted. DLS revealed unimodal population corre-
sponding to dispersion of ZnO nanoparticles in Fig. 2.
DLS studies indicates that a Dh of 15–50 nm nanoparticles
size range due to some degree of agglomeration.
Fig. 1 FESEM image of with EDX for ZnO nanoparticles (\5 nm)
Fig. 2 DLS graph showing particles size distribution of ZnO
nanoparticles
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For long-term storage, it was found more useful to
synthesize the ZnO nanoparticles by following the first
suggested procedure. UV–Vis spectra of such synthesized
nanoparticles are given in Fig. 3. Upon comparison with
the reported literature data, it is evident that the prepared
nanoparticles have typical characteristics of ZnO crystals
and their diameter, calculated by theoretical simulations
should lie below 3–4 nm.
A UV–Vis spectrum of these ZnO nanoparticles, shown
in Fig. 2, gives broad absorption band. Such behaviour is
typical of ZnO nanoparticles, which are known for broad
spectrum UV blocking. Upon conjugation with BSA, new
notable absorption peak appears at lower wavelength
(218 nm) demonstrating the formation of ZnO-protein
conjugate (Fig. 4). Researchers in the past have reported
that during nanoparticles-BSA conjugation, the protein
undergoes substantial conformational changes at both
secondary and tertiary structure levels. These changes are
related with the pH of the reaction medium, which deter-
mines the extent of blue shift in UV region.
The fluorescence spectra of the ZnO-BSA solutions
indicate that the fluorescence spectra changed obviously
when ZnO conjugated with BSA. The photoluminescence
peak position from 640 nm for pure ZnO emission to
633 nm for ZnO-BSA was accompanied with the decrease
in the fluorescence intensity after the addition of BSA
(Fig. 5).
Conclusions and future scope
It has been demonstrated that ZnO nanoparticles can be
conjugated with BSA. Further studies are required to
conclude the mechanism of conjugation, optimization of
parameters, fluorescence studies and structural investiga-
tions of the prepared conjugate. ZnO nanoparticles or
similar kind of fluorescent nanostructures can be conju-
gated with specific biomarkers for the identification of
breast cancer cells.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
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Fig. 3 UV–Vis spectra of ZnO nanoparticle














































































Fig. 5 Photoluminescence intensity of ZnO-BSA conjugates
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